Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
CVD Equipment Corporation (NASDAQ:CVV), a leading provider of chemical vapor deposition systems and materials (the "Company"), today announced it has entered into an agreement to sell and lease back its Central
CVD Equipment Corporation (NASDAQ:CVV), a leading provider of chemical vapor deposition systems and materials, today announced that Richard Catalano has been appointed as Chief Financial Officer, effective August 30,